82
61
Growth Score 82 in past quarter
-5 pts
Heat Score 61 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
382225
OrthoTreat is a drug development company devoted to developing safe & effective solutions for faster & improved healing from bone injuries.
- Sahar Meiron: Chief Executive Officer
- Joshua Shlomiuk: Chief financial Officer
Treat Group
About the Company
OrthoTreat specializes in combinatorial therapies and develops solutions in the field of orthopedic medicine through a variety of product lines tailored to human and veterinary markets. The company's core drug is designed to enhance drastically the natural healing process.